Stock listing

PSNL Stock Price, News, Filings & Events — Personalis, Inc.

Selected listing: PSNL · BOATS · USD · US

This page tracks Personalis, Inc.'s PSNL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PSNL:BOATS. PSNL:BOATS is the stock-level entry point for investors researching Personalis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Personalis, Inc. (ticker: PSNL) is a public company based in the United States, specializing in genomics and personalized medicine. With a market capitalization of approximately $1.26 billion, the company focuses on providing advanced genomic sequencing and analysis services to enhance cancer treatment and precision medicine. Personalis aims to improve patient outcomes through innovative technology and data-driven insights.

PSNL:BOATSUSDUSUpdated August 28, 2026
Personalis, Inc. logo
Ticker
PSNL:BOATS
Asset type
Stock
Market cap
$1.82B
Sector
Health Services
Industry
Medical/Nursing Services
Exchange
BOATS
Currency
USD

Personalis, Inc. PSNL:BOATS stock context

This page tracks Personalis, Inc.'s PSNL:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PSNL:BOATS. PSNL:BOATS is the stock-level entry point for investors researching Personalis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Personalis, Inc. (ticker: PSNL) is a public company based in the United States, specializing in genomics and personalized medicine. With a market capitalization of approximately $1.26 billion, the company focuses on providing advanced genomic sequencing and analysis services to enhance cancer treatment and precision medicine. Personalis aims to improve patient outcomes through innovative technology and data-driven insights.

Latest news from Personalis, Inc.

All Personalis, Inc. news →

Personalis, Inc. earnings calls

Research Personalis, Inc.

Alternate listings